About
Biosimilars
Areas of Focus
Categories
BiosimilarsChina
Clinical Trials (44)
View allTotal Trials
44
As Lead Sponsor
44
As Collaborator
0
Total Enrollment
8,262
By Phase
PHASE1: 22PHASE3: 12PHASE2: 7PHASE1/PHASE2: 3
By Status
COMPLETED: 20NOT_YET_RECRUITING: 12RECRUITING: 7ACTIVE_NOT_RECRUITING: 4WITHDRAWN: 1
Clinical Trials Pipeline44 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07128888Lead Sponsor
Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
PHASE1Not yet recruiting
60 participants
Started: Nov 17, 2025 · Completed: Jul 5, 2026
NCT07193147Lead Sponsor
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
PHASE1Not yet recruiting
36 participants
Started: Oct 13, 2025 · Completed: Nov 4, 2026
NCT07165223Lead Sponsor
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
PHASE3Not yet recruiting
300 participants
Started: Sep 28, 2025 · Completed: Nov 10, 2026
NCT07150975Lead Sponsor
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
PHASE3Not yet recruiting
420 participants
Started: Sep 15, 2025 · Completed: Jun 30, 2027
NCT07146347Lead Sponsor
Comparison Study of Insulin GZR4 With Insulin Degludec
PHASE1Recruiting
14 participants
Started: Aug 15, 2025 · Completed: Jun 1, 2026
Locations (1)
Headquarters
Beijing, China
Map
Loading map...